Correlation Between Agilent Technologies and Zymeworks Common
Can any of the company-specific risk be diversified away by investing in both Agilent Technologies and Zymeworks Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agilent Technologies and Zymeworks Common into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agilent Technologies and Zymeworks Common Stock, you can compare the effects of market volatilities on Agilent Technologies and Zymeworks Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agilent Technologies with a short position of Zymeworks Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agilent Technologies and Zymeworks Common.
Diversification Opportunities for Agilent Technologies and Zymeworks Common
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Agilent and Zymeworks is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Agilent Technologies and Zymeworks Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zymeworks Common Stock and Agilent Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agilent Technologies are associated (or correlated) with Zymeworks Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zymeworks Common Stock has no effect on the direction of Agilent Technologies i.e., Agilent Technologies and Zymeworks Common go up and down completely randomly.
Pair Corralation between Agilent Technologies and Zymeworks Common
Taking into account the 90-day investment horizon Agilent Technologies is expected to generate 12.5 times less return on investment than Zymeworks Common. But when comparing it to its historical volatility, Agilent Technologies is 1.79 times less risky than Zymeworks Common. It trades about 0.02 of its potential returns per unit of risk. Zymeworks Common Stock is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 1,159 in Zymeworks Common Stock on September 4, 2024 and sell it today you would earn a total of 291.00 from holding Zymeworks Common Stock or generate 25.11% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Agilent Technologies vs. Zymeworks Common Stock
Performance |
Timeline |
Agilent Technologies |
Zymeworks Common Stock |
Agilent Technologies and Zymeworks Common Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Agilent Technologies and Zymeworks Common
The main advantage of trading using opposite Agilent Technologies and Zymeworks Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agilent Technologies position performs unexpectedly, Zymeworks Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zymeworks Common will offset losses from the drop in Zymeworks Common's long position.Agilent Technologies vs. Danaher | Agilent Technologies vs. Illumina | Agilent Technologies vs. IDEXX Laboratories | Agilent Technologies vs. Waters |
Zymeworks Common vs. Day One Biopharmaceuticals | Zymeworks Common vs. Inozyme Pharma | Zymeworks Common vs. Zentalis Pharmaceuticals Llc | Zymeworks Common vs. Syndax Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |